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Abstract 
Hydroxyapatite and chitosan are widely used in biomedical applications due to 
their biocompatibility and biodegradability. Various studies show that composites made 
of hydroxyapatite and chitosan exhibit desirable properties for applications in bone tissue 
engineering. When creating a composite it is important to understand the interfacial 
chemistry and physical interactions between the composite materials. An understanding 
of these properties gives more insight into the resulting structure of the composite on 
multiple levels (nano- micro- macro). This structure affects the chemical, physical, and 
mechanical properties of the material, thus analysis of these properties gives a better 
understanding of how a material will perform when used in various applications. The 
goal of this research project was to explore the chemical and physical interactions that 
occur between hydroxyapatite nanoparticles (HANPs) and the polymer chitosan in a 
novel nanocomposite. 
In this project, composites of HANPs and chitosan were synthesized using 
varying concentrations of the two materials. The composites were analyzed through 
particle size analysis, Scanning Electron Microscopy (SEM), Dispersive X-ray 
spectroscopy (EDX), Nuclear Magnetic Resonance spectroscopy (NMR), and X-ray 
Diffraction (XRD). The results of the study showed mixtures of 10% chitosan and 90% 
HANPs (dry weight fraction) produce composites with the smallest particle size. The 
particle size of this composite was then further reduced through chemo-mechanical 
processing to create a nanocomposite. NMR data suggests that chemical interactions 
occur between the materials and from analysis of their chemical structures these 
interactions are most likely hydrogen bonding and coordination bonds. XRD analysis 
shows a phase change does not occur in the composite after mixing, however there are 
some phase changes after chemo-mechanical processing.
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Introduction 
The prevalence of patients with bone loss and fracture from various diseases continues to 
increase in the United States. Among these diseases is osteoporosis, which causes a decrease in 
bone mineral density [1–3]. Several solutions to the problem of bone loss exist today, including 
bone autografts and allografts, however both of these treatments have their own disadvantages. 
Bone autograft complications include insufficient wound healing, donor pain, and insufficient 
bone material to fill fractures and gaps. Allografts on the other hand pose threats of patient 
immune reactions and transmissible diseases [4]. Another solution to the problem of bone loss is 
bone implants made of hydroxyapatite, glass-ceramics, or titanium [5]. In the area of vertebrae 
bone density loss, injectable polymer methyl methacrylate (PMMA) composites are most 
common. These composites are normally used in vertebroplasty in which PMMA is injected into 
a vertebra with decreased bone density or fracture. The use of PMMA in this application 
however poses various problems. After injection, the polymer’s dense nature can lead to 
subsequent vertebrae compression fractures. Other negative aspects include failure to  adhere to 
surrounding bone surfaces, high exothermic reaction temperature, and insufficient degradation in 
the body [3]. 
In recent years mixtures of nanoparticles in different dispersion media have become a 
common method for drug delivery and tissue repair. In general nanoparticles are preferred in 
these applications when compared to microparticles because they have distinct properties that 
can be tuned during synthesis. Nanoparticles also resemble the size of biological molecules (e.g. 
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proteins, DNA, signal molecules) and structures (e.g. viruses and bacteria), which allows them to 
better interact with the native, target tissues [6].  
Due to the desirable properties of nanoparticles, the goal of this project was to create a 
composite made of nanoparticles for use in bone tissue repair. This composite would be used in 
patients by injecting it into areas of bone loss or bone fracture.  After creating this composite, the 
goal was to explore the chemical and physical interactions between the nanoparticles and the 
dispersion medium. Understanding this interfacial chemistry between the materials gives insight 
into the resulting nano- micro- macro structure, which affects the physical and chemical 
properties of material. By understanding these properties, a better understanding is gained of 
how the material will perform when used in various applications. 
There are many kinds of nanoparticles used in different biomedical applications. 
Examples can be found in Table 1 and of these materials, hydroxyapatite and silica are used in 
bone tissue applications. Along with these are various materials used as dispersion media to 
carry the nanoparticles inside the body (Table 2). All of these dispersion media however have 
various drawbacks for this project. 
 
Table 1. Nanoparticles for Biomedical Applications 
Nanoparticle Material Biomedical Application 
Hydroxyapatite Bone repair/growth [7] 
Silica Bone repair/growth [8] 
Gold Tumor targeting [9] 
Albumin Tumor targeting [10] 
Glycol Chitosan Low water soluble drugs [11] 
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Table 2. Common Nanoparticle Dispersion Media 
Dispersion Medium Drawbacks 
Methyl Methacrylate Low osteoconductivity, cell attachment and proliferation [1,3] 
Alginate Hydrogel Preparation time more than 24 hours [12] 
Carboxymethyl Chitin 
Difficult to prepare from chitin; commercial sources not 
economical [13] 
Carboxymethyl Chitosan 
Difficult to prepare from chitin and chitosan; commercial 
sources not economical [14] 
 
In recent years, hydroxyapatite and chitosan have become common materials used in the 
area of bone tissue engineering. Composites made of these materials have proved to be more 
promising for bone repair and replacement when compared to other materials and treatment 
methods [4]. 
Hydroxyapatite [Ca10(PO4)6(OH)2] is a major inorganic component of the human body 
[15,16]. It is known to be biocompatible, bioactive, and has been used successfully in various 
biomedical applications [13,17–19]. As seen in Figure 1, hydroxyapatite has a hexagonal crystal 
structure. For pure hydroxyapatite, the calcium phosphate ratio is 1.67 [20]. Pure hydroxyapatite 
however has poor mechanical properties, including brittleness, and is difficult to mold into a 
desired shape. Its direct implantation also results in displacement of the material from its 
intended tissue [12,16]. Thus, hydroxyapatite by itself is a poor biomaterial, despite its positive 
biological properties. 
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Figure 1. Crystal Structure of Hydroxyapatite [21] 
 
Chitosan is biocompatible, non-toxic, biorenewable, and biodegradable [22–24]. It is also 
known to promote cell growth and has been used in numerous biomedical applications such as 
wound dressings and drug delivery [14,24]. Chitosan is a linear, heteropolysaccharide consisting 
of β-1,4-linked glucosamine and N-acetylglucosamine units (Fig. 2). This linkage results in a 
rigid and unbranched structure. The crystalline structure and presence of hydroxyl groups allow 
for both intra- and intermolecular hydrogen bonding [24]. In previous studies, chitosan has been 
used as an adhesive to solve the problem of hydroxyapatite displacement and to allow for 
molding of hydroxyapatite into a desired shape [23]. 
 
Figure 2. Primary Structure of Chitosan [24] 
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Methods 
In this project, chitosan was used as the dispersion medium for hydroxyapatite 
nanoparticles (HANPs) to create a novel nanocomposite. Chemo-mechanical processing in the 
form of ball-milling was used to make the final nanocomposite. Various chemical and physical 
properties of the composite were analyzed. Chemical properties of the composites were explored 
using energy dispersive X-ray spectroscopy (EDX) for elemental analysis and nuclear magnetic 
resonance spectroscopy (NMR) for functional group analysis. Physical characterization included 
particle size analysis using a particle analyzer and scanning electron microscopy (SEM), and 
phase characterization was performed using X-ray diffraction spectroscopy (XRD).  
Composite Preparation  
HANPs were purchased from Nanoshel (Wilmington, Del.) and low molecular weight 
chitosan powder was purchased from Sigma Aldrich (St. Louis, Mo.). Four composites were 
prepared with varying fractions of HANPs and chitosan powder. Composites consisted of 10%, 
30%, 50%, and 70% chitosan by weight and corresponding weight fraction of  HANPs (Table 3). 
Each sample was prepared by mixing chitosan powder with water and 2% acetic acid. HANPs 
were then added and the solution was mixed for six hours at 37°C and 800rpm. 
Table 3. Weight Fractions of Prepared Composites 
Composite Chitosan (%wt) HANPs (%wt) 
1 10 90 
2 30 70 
3 50 50 
4 70 30 
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Chemo-Mechanical Processing 
The goal of the study was to create a novel nanocomposite between chitosan and HANPs. 
Particle size analysis showed that none of the prepared composites consisted of particles within 
the nanometer range, thus the particle size of the composite needed to be further reduced. 
Because Composite 1 produced the smallest particle size, this fraction of materials was used for 
further particle size reduction. In order to reduce the size of the particles, chemo-mechanical 
processing in the form of ball-milling was performed on samples of Composite 1. A ceramic 
zirconia vial and ceramic zirconia balls were used in combination with a ball-mill for processing. 
Samples of Composite 1 were ball-milled for 36 hours to determine if particle size could be 
further reduced. 
Results 
Particle Size Determination 
Starting Materials 
The particle size of HANPs and chitosan powder was analyzed using a laser diffraction 
particle size distribution analyzer (Partica LA-950, Horiba, Houston, TX) and scanning electron 
microscopy (SEM) (Fig. 3,4). Particle size for each sample was determined from SEM images 
using ImageJ software. 
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Figure 3. SEM of Hydroxyapatite Nanoparticles 
 
 
Figure 4. SEM of Chitoan Powder 
 
Mean particle size of chitosan powder was determined to be 218μm with particle 
analyzer. Mean particle size of chitosan from SEM analysis was determined to be 204μm. Mean 
particle size of HANPs was determined to be 275nm with particle analyzer. Mean particle size of 
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HANPs from SEM analysis was determined to be 82.5nm. The inconsistency in measured data 
between particle size analyzer and SEM images for HANPs is believed to be associated with 
HANPs agglomeration in analysis with the particle analyzer. SEM images confirm that 
individual HANPs particles are less than 100nm. 
Composites 
All four composites were analyzed through SEM (Fig. 5-8). Samples of each composite 
were dried before SEM analysis and coated through gold sputtering. Particle size for each 
composite was determined through SEM images using ImageJ software.  Measurements were 
repeated on three different samples for each of the four composites. Each of the three samples 
was measured three times for a total of nine measurements for each composite (Table 4). 
 
Figure 5. SEM Composite 1 
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Figure 6. SEM Composite 2 
 
 
Figure 7. SEM Composite 3 
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Figure 8. SEM Composite 4 
 
Table 4. Particle Size of Composites 
Composite Particle Size* 
1 15.9μm 
2 113μm 
3 190μm 
4 22.0μm 
*Based on preliminary visual data 
Particle size analysis showed that Composite 1 (90% HANPs, 10% chitosan) produced 
the smallest particles, however none of the composites had consistent particle size within the 
nanometer range. 
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Chemo-Mechanical Processed Composites 
Samples of Composite 1 were ball-milled for 36 hours to determine if particle size could 
be further reduced. Average particle size was measured with a particle size analyzer. Results of 
particle size analysis for three different samples after 36 hours of ball-milling can be found in 
Table 5. SEM of Composite 1 after 36 hours of ball-milling can be found in Figure 9. 
Table 5. Average Particle Size of Composite 1 after Chemo-Mechanical Processing 
Composite 1 
Sample 
Initial Average 
Particle Size 
Average Particle Size 
After Processing 
1 778 nm 516 nm 
2 661 nm 285 nm 
3 536 nm 436 nm 
 
 
Figure 9. SEM of Composite 1 after Chemo-Mechanical Processing 
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Chemo-mechanical processing of samples through ball-milling successfully reduced the 
particle size of the composite. SEM images of the ball-milled composite reveal that individual 
particles are less than 100nm, however particles appear to be fused together. 
Energy Dispersion X-ray Spectroscopy (EDX) 
EDX was performed using the EDX function on a scanning electron microscope for each 
of the four composites. Results of EDX analysis for samples of composites can be found in 
Figures 10-13. 
 
Figure 10. EDX of Composite 1 
 
 
Figure 11. EDX of Composite 2 
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Figure 12. EDX of Composite 3 
 
Figure 13. EDX of Composite 4 
EDX analysis of all composites showed areas of calcium, phosphorus, and oxygen. All 
these elements are found in hydroxyapatite, however of these elements only oxygen is present in 
chitosan. Further analysis needs to be done in the future to determine if carbon and nitrogen are 
present in the samples and were undetected by EDX. 
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Nuclear Magnetic Resonance Spectroscopy (NMR) 
In order to determine the functional groups present in the composites, NMR spectroscopy 
was performed on samples of each composite (Fig. 14-17). 
 
Figure 14. NMR of Composite 1 
 
Figure 15. NMR of Composite 2 
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Figure 16. NMR of Composite 3 
 
Figure 17. NMR of Composite 4 
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NMR revealed hydroxyl groups in each composite, however only Composite 1 showed 
the amine group from chitosan.  
X-Ray Diffraction Spectroscopy (XRD) 
To determine if phase changes occurred between the starting materials and composite, 
powder x-ray diffraction was performed on samples of chitosan powder, HANPs, Composite 1, 
and Composite 1 after 36 hours of ball-milling (Fig. 18). 
 
 
Figure 18. XRD of chitosan powder, HANPs, Composite 1, and Composite 1 after 36 hours ball-milling 
 
The major peaks measured for chitosan powder and HANPs, match peaks found in 
previous studies [25,26]. Composite 1 retained a similar crystal structure to HANPs as the XRD 
spectra for the two samples have nearly identical peaks. The (100) and (020) peaks found in 
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chitosan powder are absent in both Composite 1 and Composite 1 after ball-milling. Both 
Composite 1 and Composite 1 after ball-milling retained the (002) peak characteristic of HANPs 
[26,27]. After ball-milling the (002) peak in Composite 1 showed increased intensity. Several 
new peaks appeared in Composite 1 after ball-milling.  
 
Discussion 
Particle size analysis 
Particle size analysis showed that the optimal fraction for making a chitosan-HANPs 
nanocomposite is 10% chitosan powder and 90% HANPs (dry weight fraction). Though none of 
the initial composites had particle sizes within the nanometer range, chemo-mechanical 
processing successfully reduced the particle size to a desired range. 
EDX 
EDX analysis revealed that the surface of the composites was mostly composed of 
calcium, phosphorus, and oxygen. These results may show that hydroxyapatite is the 
predominant material on the surface of composite particles. Further testing of the processed 
materials needs to be performed to understand if the composite consists of chitosan particles 
coated in HANPs. 
NMR 
NMR data showed some chemical properties of the starting materials remained distinct in 
the composite, including hydroxyl groups and some amine groups in Composite 1. The absence 
of the amine group in Composites 2-4 could be explained by the potential coordination bond 
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between the amine groups of chitosan and the Ca
2+
 ions of hydroxyapatite (Fig. 19). From the 
structure of the two materials, the particles may also be held together by hydrogen bonding, but 
further analysis is necessary to confirm this bonding. 
 
Figure 19. Possible Coordination Bond between Hydroxyapatite and Chitosan [4] 
XRD 
XRD analysis revealed Composite 1 retained major crystal properties of HANPs both 
before and after chemo-mechanical processing. Several new peaks appeared after processing. 
Further studies are necessary to determine if these peaks represent new crystal structures, 
increased intensity of existing structures, or contamination by the zirconia ceramic vial and balls.  
Conclusions 
It was determined through this study that the optimal fraction for making a chitosan-
HANPs nanocomposite is 10% chitosan powder and 90% HANPs. Through chemo-mechanical 
processing the average particle size of this composite was reduced from 778nm to 285nm.  
The outcomes of this project were a method for mixing chitosan powder and HANPs to 
make a nanocomposite. Chemical analysis through EDX and NMR showed that some of the 
chemical properties of the starting materials remained distinct in the composite, however there is 
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some evidence of a coordination bond between the amine groups of chitosan and the Ca
2+
 ions of 
hydroxyapatite. Analysis of composites through XRD revealed that Composite 1 retained the 
major crystal properties of HANPs both before and after chemo-mechanical processing, however 
several new peaks appeared after processing. More experiments must be conducted to confirm 
whether these peaks are evidence of new crystal phases, intensification of existing phases, or 
contamination from processing. 
Future Directions 
Sample Preparation 
An ideal composite will be one in which chitosan particles and HANPs are evenly 
dispersed. In order to create such a composite and one with even further reduced particle size, the 
particle size of chitosan powder should be closer to that of HANPs. One way to achieve this 
would be processing the chitosan powder through chemo-mechanical processing before mixing 
with HANPs. 
In vivo Studies 
Samples of Composite 1 have been sent to the University of Arkansas for Medical 
Sciences (UAMS) in Little Rock, Arkansas. Ernest Ferris, M.D., of the Department of 
Radiology, will be conducting in vivo studies in rabbits with the composite to determine the 
immune response and osseointegration of the composite. 
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